Extreme Lateral Interbody Fusion (XLIF) Surgery Market
According to Intent Market Research, the Extreme Lateral Interbody Fusion (Xlif) Surgery Market is expected to grow from USD 1.0 billion in 2023 at a CAGR of 8.0% to touch USD 1.7 billion by 2030. The Extreme Lateral Interbody Fusion (Xlif) Surgery Market is dominated by key players such as Medtronic, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., DePuy Synthes (Johnson & Johnson), B. Braun Melsungen AG, K2M Group Holdings, Inc., Orthofix Medical Inc., SeaSpine Holdings Corporation, Aesculap Implant Systems, LLC, RTI Surgical Holdings, Inc., Xtant Medical Holdings, Inc.